Cellebrite DI Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Cellebrite DI Ltd. covers the period ending December 1, 2021. The report serves to announce the results of a special general meeting of shareholders held on November 29, 2021, in accordance with the Israeli Companies Law.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a corporate governance update rather than a financial performance report.
Material Changes
The primary material event reported is the shareholder approval of all proposals presented at the special meeting. Attendance was significant, with 153,400,353 ordinary shares present or represented by proxy, representing approximately 81.95% of the issued and outstanding ordinary shares as of the record date.
Guidance, Outlook, and Risks
The filing contains no management commentary regarding future guidance, outlook, risks, contingencies, or unusual items. It strictly confirms the successful ratification of proposals previously detailed in the Proxy Statement filed on October 21, 2021.
Key Facts for Investors to Verify
- Confirmation that all shareholder proposals from the November 29, 2021 meeting were approved by the requisite majority.
- Verification of the 81.95% shareholder participation rate at the special meeting.
- Review of the specific proposals approved, which are detailed in the Proxy Statement (Exhibit 99.1) filed on October 21, 2021.